The global periodontal therapeutics market size was valued at US$ 0.64 billion in 2021 and expected to reach US$ 1.38 billion by 2030 with a CAGR of 8.9% from 2022 to 2030.
The global periodontal therapeutics market size was valued at US$ 0.64 billion in 2021 and expected to reach US$ 1.38 billion by 2030 with a CAGR of 8.9% from 2022 to 2030.
Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/35595
Rise in reported cases of periodontitis, Increase in prevalence of diabetes, rise in global geriatric population and surge in awareness about oral health are projected to drive the global periodontal therapeutics market
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 0.64 billion |
| Revenue Forecast by 2030 | USD 1.38 billion |
| Growth rate from 2022 to 2030 | CAGR of 8.9% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Product, Distribution Channel, Region |
| Companies Covered | Den-Mat Holdings, LLC, Valeant Pharmaceuticals International, Inc., Dexcel Pharma, 3M Company, Oral Science, and Kaken Pharmaceutical Co., Ltd. |
Local Antibiotics Segment to Account for Significant Market Share
- Surge in awareness about oral health primarily driven by national and community policies regarding effective control on diet and nutrition risk factors for oral diseases such as periodontal and dental disease, and development of novel products for the treatment of periodontal diseases are expected to provide fillip for antibiotic based treatment options. Companies can also focus on introducing locally applied antibiotics in countries with sizeable population affected with periodontal diseases in order to capitalize on the large unmet needs in these countries.
- The growth of the segment can be attributed to the advantages offered by locally applied antibiotics over systemic antibiotics. Local route of drug delivery provides 100-fold higher concentrations of an antimicrobial agent in the subgingival sites in comparison to a systemic drug regimen, which, in turn, reduces the total patient dose by more than 400-fold
- Local antibiotics also help in reducing the potential problems associated with the use of systemic antibiotic drugs and can negate the development of drug resistant microbial population in non-oral body sites
- Additionally, focus of pharmaceutical companies on the development of improved local antibiotics is expected to further boost the demand for these products
Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/35595
Opportunities
Increasing therapeutic Advancements in Periodontal Therapeutics
The burden of periodontal diseases has guided various leading market players to increase their research and development for periodontal therapeutics. Research and development for new advanced periodontal therapeutics are expected to increase adoption of periodontal therapeutics for the treatment of periodontal disease. Currently, various manufacturers are in the development phase and some have already launched clinical trials for periodontal therapeutics which is expected to fulfil demand and create new opportunities for periodontal therapeutics market.
Growing awareness regarding Periodontal Disease
Governments, international organizations and regulatory authorities in various developing nations are making huge efforts for increasing awareness for diagnosis and treatment of periodontal diseases. Increasing focus on raising awareness for diagnosis and treatment of periodontal diseases is expected to untapped the potential markets in the emerging nations by increasing the diagnosis and treatment rate and increasing public spending towards it. Due to this reason the factor is expected to create various opportunities for the periodontal therapeutics market.
Prominent Regions
- North America held the largest share of the global periodontal therapeutics market in 2018. The market in the region is projected to grow at a rapid pace during the forecast period, driven by presence of key players, high adoption of technological advancements, and highly structured health care industry.
- Increase in clinical trials, product launches & approvals, and rise in investment by key players are projected to propel the periodontal therapeutics market in North America
- The U.S. is anticipated to dominate the periodontal therapeutics market in the region during the forecast period. People in the U.S. are living longer and keeping more of their teeth in old age. As the elderly population increases, its oral health needs and ability to access care are gaining more attention. An estimated 70% of seniors lack or have limited dental insurance, and fewer than half access dental care each year.
- The health care delivery system is changing rapidly with the implementation of the Affordable Care Act. Millions of previously uninsured low-income adults gained coverage under the Affordable Care Act’s Medicaid expansions.
- The percentage of people covered by any type of health insurance increased by 1.3 percentage points to 90.9% in 2015, up from 89.6% in 2014. In 2015, private health insurance coverage continued to be more prevalent than public coverage, at 67.2% and 37.1%, respectively.
Key Players
- Key players in the global periodontal therapeutics market focus on strengthening their positions in the global market
- Players are collaborating with other companies, actively conducting research studies, participating in mergers & acquisitions, and increasing product approvals and launches to secure and strengthen their positions in the global periodontal therapeutics market.
- In February 2020, Oral Science announced its decision to launch Fluorimax, a next-generation of fluoride varnishes intended to be used for the treatment of dental caries
- Major players operating in the global periodontal therapeutics market include Den-Mat Holdings, LLC, Valeant Pharmaceuticals International, Inc., Dexcel Pharma, 3M Company, Oral Science, and Kaken Pharmaceutical Co., Ltd.
Related Reports
- Nucleic Acid Based Therapeutics Market Report 2022-2030 - https://www.visionresearchreports.com/nucleic-acid-based-therapeutics-market/39802
- Microbiome Therapeutics Market Report 2022-2030 - https://www.visionresearchreports.com/microbiome-therapeutics-market/39454
- mRNA Therapeutics Market Report 2022-2030 - https://www.visionresearchreports.com/mrna-therapeutics-market/39429
The global periodontal therapeutics market has been segmented as follows:
By Product
-
- Systemic Antibiotics
- Arestin
- Periochip
- Atridox
- Others
- Local Antibiotics
- Arestin
- Atridox
- PerioChip
- Others
- Systemic Antibiotics
By Distribution Channel
-
- Hospitals Pharmacies
- Retail Pharmacies
- Drug Stores
- E-Commerce
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/35595
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://qyresearchmedical.com/